Clinical Trial

Patient-derived Tumor-like Cell Cluster Model-based Precision Treatment Strategy on Non-small Cell Lung Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
This trial is a prospective, observational study of non-small cell lung cancer that aims to evaluate the feasibility, preliminary efficacy and safety of patient-derived tumor-like cell cluster model in guiding the precision treatment strategy.
Trial Details
NCT Number NCT07328945
Lead Sponsor Shanghai Pulmonary Hospital, Shanghai, China
Conditions Non-small Cell Lung Cancer
Enrollment 250 participants
Start Date 2023-12-01
Primary Completion 2027-01 (estimated)
Study Completion 2028-07 (estimated)
Updated on ClinicalTrials.gov 2026-01-09